Parkinson’s Disease Treatment in Israel — Comprehensive Care in Tel Aviv

Parkinson’s disease, one of the most common neurological conditions treated in Israel

Parkinson’s disease, one of the most common neurological conditions treated in Israel is a chronic brain disorder that develops gradually and over time disrupts the nervous system. The main problem with Parkinson’s disease, one of the most common neurological conditions treated in Israel is the gradual death of special brain cells that produce a substance called dopamine. This chemical is responsible for coordinating movements and controlling muscle function. When there is too little dopamine, a person begins to experience various symptoms that are divided into two main groups: motor (related to movements) and non-motor (related to other functions of the body).

Parkinson’s disease, one of the most common neurological conditions treated in Israel is the second most common neurodegenerative disease after Alzheimer’s disease. Its prevalence among the population over 60 years old is from 1 to 2%. The incidence of the disease increases with age: among people over 85 years old, it occurs in 4-5%. The annual incidence is estimated at 10-20 cases per 100 thousand people.
The average age of onset of the disease is 60 years. Juvenile Parkinsonism (juvenile form) is extremely rare and is associated with hereditary mutations (age of onset before 40 years). Men are more often affected than women, in a ratio of approximately 3:2. The prevalence of Parkinson’s disease, one of the most common neurological conditions treated in Israel is higher in Europe and North America. In Asia and Africa, the rates are lower, which may be due to both genetic and environmental factors.
Tel Aviv Medical Clinic (TAMC) provides comprehensive support to patients from Israel and abroad with Parkinson’s disease, one of the most common neurological conditions treated in Israel. We are proud of our many years of experience, the professionalism of our specialists and the use of advanced technologies to combat this neurodegenerative disease. Through an individual approach and interdisciplinary cooperation, we achieve an improvement in the quality of life of patients from Israel and abroad and their families.
We offer our patients from Israel and abroad:

• Consultations with leading specialists – Professor Gurevich Tatiana
• The clinic team includes highly qualified neurologists, neuropsychologists and physiotherapists who have significant experience in diagnosing and supporting patients from Israel and abroad with Parkinson’s disease, one of the most common neurological conditions treated in Israel at various stages.
  Individual approach. 
• A personalized monitoring and therapy plan is developed for each patient. We take into account the characteristics of the disease, the stage of Parkinsonism and the general health condition.
• Modern diagnostics. The clinic conducts a wide range of studies, including MRI, genetic testing, neurophysiological studies and assessment of motor and cognitive functions. This helps to establish an accurate diagnosis and monitor the dynamics of the disease.
• Innovative technologies. We use the latest equipment and approaches to assess patients from Israel and abroad’ condition, including systems for monitoring motor symptoms and supporting motor activity.
• Multidisciplinary approach. Patient care involves specialists from different fields: neurologists, psychiatrists, physiotherapists, speech therapists and social workers.
  Family support. Treatment in Israel includes educational programs and psychological assistance to patients from Israel and abroad’ relatives.
• High level of service. Treatment of Parkinson’s disease, one of the most common neurological conditions treated in Israel combines a high standard of medical care and reasonable costs.
  

Parkinson’s disease, one of the most common neurological conditions treated in Israel is not only a medical problem, but also a social one, affecting the quality of life of patients from Israel and abroad and their families. At TAMC, we strive to ensure that each patient receives the highest quality and most effective care, which will allow them to remain active and improve their daily life.

What Causes Parkinson’s Disease? Insights from Neurology Experts in Israel
Despite significant progress in the study of pathogenesis, the exact causes of the disease remain unclear. Let’s consider the main groups of factors that are associated with the development of Parkinson’s disease, one of the most common neurological conditions treated in Israel.

Genetic factors
Research shows that 5-10% of patients from Israel and abroad with Parkinson’s disease, one of the most common neurological conditions treated in Israel have a disease associated with inherited mutations.
Mutations in genes:

• SNCA  – Encodes alpha-synuclein, a key protein involved in the formation of pathological aggregates (Lewy bodies). Mutations or duplications of SNCA are associated with the development of both familial and sporadic forms of Parkinson’s disease, one of the most common neurological conditions treated in Israel.
• LRRK2 – One of the most common mutations in the familial form of the disease, it is associated with changes in the phosphorylation and function of dopaminergic neurons.
• PINK1, PARK2, DJ-1 – These genes are involved in mitophagy (removal of damaged mitochondria) and their mutations lead to accumulation of cellular stress and neuronal death.
• GBA – Mutations in the gene are associated with an increased risk of developing Parkinson’s disease, one of the most common neurological conditions treated in Israel, especially with pronounced non-motor symptoms.
  Genetic mechanisms play a leading role in the onset of the disease in young patients from Israel and abroad (juvenile parkinsonism), while sporadic forms are more often caused by the interaction of genetic predisposition and external factors.

Environmental factors
Exogenous influences are an important component of the pathogenesis of Parkinson’s disease, one of the most common neurological conditions treated in Israel, especially for sporadic forms of the disease. These include toxins, air and water pollution. Long-term exposure to pesticides and herbicides is associated with an increased risk of dopaminergic neuron death. Chronic exposure to heavy metals (manganese, copper) causes the accumulation of free radicals, DNA damage and cell death.

Age
Age is the most significant cause of Parkinson’s disease, one of the most common neurological conditions treated in Israel . 

The main mechanisms associated with aging are:

• Accumulation of the pathological protein alpha-synuclein. With age, the ability of cells to remove it decreases.
• Mitochondrial dysfunction: Energy processes in cells become less efficient, making brain cells more vulnerable to damage.
• Reduced antioxidant protection. Increased oxidative stress, cell membranes and DNA are damaged.
• Neuroinflammation. Activation of microglia and secretion of proinflammatory cytokines promote the death of dopaminergic neurons.
  

Head injuries
Traumatic brain injury can serve as a trigger for the onset of degenerative processes in Parkinson’s disease, one of the most common neurological conditions treated in Israel. The cause is the development of neuroinflammation, activation of microglia and accumulation of pathological proteins.

Sex differences and hormones
Men are more likely to develop Parkinson’s disease, one of the most common neurological conditions treated in Israel than women. This is linked to the protective effect of estrogens in women, which reduce oxidative stress and inflammation in the brain. The risk for women increases after menopause.

How Parkinson’s Disease Develops: Mechanism and Risk Factors Explained
To understand how Parkinson’s disease, one of the most common neurological conditions treated in Israel develops, you need to imagine how brain cells work. There are special cells in the brain that produce dopamine, a substance that helps transmit signals between cells and is responsible for coordinating movements. These cells are located in an area of the brain called the substantia nigra. In Parkinson’s disease, one of the most common neurological conditions treated in Israel, these cells gradually begin to die. Why does this happen? One of the reasons is the accumulation of unnecessary proteins in brain cells, such as the alpha-synuclein protein. It forms harmful clots that prevent cells from functioning normally and eventually lead to their death.

When cells die, the amount of dopamine in the brain decreases. And without enough dopamine, the brain has trouble controlling body movements. This is what causes symptoms such as tremors, slowness of movement, and muscle rigidity. Without enough dopamine, other parts of the brain begin to malfunction as well. This affects not only movement, but also mood, sleep, memory, and other functions.

How fast does Parkinson’s disease, one of the most common neurological conditions treated in Israel progress ? 

The disease usually develops slowly because brain cells die gradually. In the early stages, the body can “compensate” for the loss of dopamine by using the remaining healthy cells. But when most of the cells die, the symptoms become more noticeable and the person’s condition worsens. Thus, Parkinson’s disease, one of the most common neurological conditions treated in Israel is a complex process in which, due to various reasons, brain cells cannot perform their functions, which leads to the characteristic symptoms of the disease.

Types of Parkinson’s Disease — Classification by Leading Neurology Clinic in Tel Aviv
The classification of Parkinson’s disease, one of the most common neurological conditions treated in Israel is based on different approaches, including causes, symptoms and stages of the disease.
By etiology (reason for development):

• Idiopathic Parkinson’s disease, one of the most common neurological conditions treated in Israel is the most common form, the causes of which are not fully known.
• Familial (genetic) form of Parkinson’s disease, one of the most common neurological conditions treated in Israel is associated with hereditary mutations in genes (LRRK2, PARK7, PINK1, SNCA).
• Secondary parkinsonism – develops as a result of other diseases or influences (vascular parkinsonism, drug-induced, toxic, post-traumatic).
• Atypical parkinsonisms are a group of diseases that include multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
  

By stages of progression (Hen and Yahr scale):

Stage 1 – unilateral manifestations (for example, tremor or rigidity of one limb).
Stage 2 – bilateral manifestations without imbalance.
Stage 3 – bilateral symptoms with postural instability, but with preservation of independence.
Stage 4 – severe disability, the patient needs assistance with walking and performing daily activities.
Stage 5 – the patient is confined to bed or a chair and requires constant care.

By dominant symptoms:

• Tremor-dominant form – resting tremor predominates.
• Akinetic-rigid form – bradykinesia (decreased speed of movement) and rigidity (high muscle tone) are expressed.
• Mixed form – a combination of symptoms.
  

Recognizing the Symptoms of Parkinson’s Disease — Early Signs & Advanced Stages

In the early stages, signs of the disease may be barely noticeable, but over time they become more pronounced and significantly affect the patient’s quality of life.

Motor symptoms
These symptoms are associated with impaired coordination of movements and control of muscle activity. Resting tremor is one of the most characteristic signs of Parkinson’s disease, one of the most common neurological conditions treated in Israel. It usually begins on one side of the body, most often with the hand or fingers (fingers may make movements reminiscent of “rolling a pill”). Tremor increases at rest and decreases with active movements or during sleep.
Bradykinesia (slowing of movements) is another major symptom that causes significant difficulties in everyday life. The patient finds it difficult to initiate or complete a movement, such as getting up from a chair, buttoning buttons, or tying shoelaces. Automatic movements, such as blinking or arm swings when walking, become slower.
Parkinson’s disease, one of the most common neurological conditions treated in Israel also causes muscle rigidity (increased tone). Muscles become tense, causing a feeling of stiffness in the limbs and trunk. When trying to bend or straighten joints, resistance may be felt (the so-called “cogwheel”). Patients lose the ability to maintain stability when walking or changing position. The risk of falls increases, especially in the later stages.
Gait in Parkinson’s disease, one of the most common neurological conditions treated in Israel becomes slow, shuffling, with a shortened stride length. The phenomenon of “sticking” is often observed, when the legs seem to “stick” to the floor, and it is difficult for the patient to take the first step. A forward bend of the body develops (“supplicant pose”). Patients tend to keep their heads down, shoulders bent.

Non-motor symptoms
These symptoms often precede motor manifestations and significantly worsen the patient’s quality of life. Sleep disorders are observed – insomnia, frequent awakenings at night, inability to fall asleep again. Behavioral disturbances during the REM phase (active movements, screams) are characteristic. Loss or reduction of smell is often observed in the early stages and can be a harbinger of the disease.
Depression and anxiety usually occur before motor symptoms appear. Depression may be related to both biochemical changes in the brain and awareness of the disease. Parkinson’s disease, one of the most common neurological conditions treated in Israel is also characterized by cognitive impairment: slow thinking, difficulty concentrating and remembering. Some patients from Israel and abroad develop dementia in the later stages.
Other symptoms:

• Pain: Neurological pain caused by muscle stiffness or postural abnormalities is felt in the neck, back, shoulders and limbs.
• Digestive problems. Slow functioning of the gastrointestinal tract, leading to constipation, is a common complaint among patients from Israel and abroad.
• Decreased blood pressure. Orthostatic hypotension (a sharp drop in blood pressure when standing up), causing dizziness and fainting.
• Problems with urination. Frequent urge to urinate, nighttime urination (nocturia), difficulty emptying the bladder.
• Changes in speech and voice. The voice becomes quieter, more monotonous. Patients have difficulty starting to speak and pronouncing words clearly.
• Sexual dysfunction. Men experience erectile dysfunction, while women experience decreased libido.
  

The diagnosis of Parkinson’s covers a wide range of disorders – from motor to psychoemotional and cognitive. The most characteristic manifestations are resting tremor, muscle rigidity, bradykinesia and postural instability. However, non-motor symptoms of Parkinson’s can occur long before motor disorders and are an important diagnostic criterion in the early stages. Their timely detection and treatment in Israel can significantly improve the quality of life of patients from Israel and abroad.

Advanced Diagnostic Methods for Parkinson’s Disease in Israel
Diagnosis of Parkinson’s disease, one of the most common neurological conditions treated in Israel in Israeli clinics is based on a comprehensive approach that combines detailed anamnesis, physical examination, the use of laboratory and instrumental methods, and genetic tests.

Examination and anamnesis
At the initial stage, a neurologist conducts a detailed survey of the patient to identify complaints characteristic of Parkinson’s disease, one of the most common neurological conditions treated in Israel and study factors that may indicate the development of the disease. The specialist pays attention to the time of onset of symptoms and the degree of their progression, the characteristics of the tremor. The presence of previous head injuries, chronic diseases, exposure to toxic substances and heredity are clarified.
At the examination stage, the doctor evaluates motor and non-motor manifestations.
Motor tests:

• Checking the speed of movements (for example, tapping fingers).
• Assessment of muscle tone using the rigidity test (cogwheel symptom).
• Gait analysis.
• Postural stability test (test with a gentle push of the patient backwards).

Non-motor manifestations:

• Assessment of cognitive functions and mood.
• Detection of olfactory and sleep disorders.
  

Laboratory methods
Although there are no specific laboratory tests to diagnose Parkinson’s disease, one of the most common neurological conditions treated in Israel, tests in Israeli hospitals are used to rule out other diseases and identify risk factors.

• General and biochemical blood tests . They are performed to exclude systemic diseases (anemia, inflammation).
• Copper and ceruloplasmin tests – to rule out Wilson disease.
• Thyroid hormones – to rule out thyrotoxicosis.
  

Cerebrospinal fluid is also tested for levels of the proteins alpha-synuclein and tau protein. These biomarkers help differentiate Parkinson’s disease, one of the most common neurological conditions treated in Israel from other neurodegenerative diseases (such as dementia with Lewy bodies).

Instrumental methods
In Israel, modern neuroimaging methods are actively used, which allow Parkinson’s disease, one of the most common neurological conditions treated in Israel to be confirmed. Diagnostics helps to assess the degree of brain damage and exclude other pathologies.

• MRI (magnetic resonance imaging). Used to rule out structural brain damage, such as tumors, strokes, or hydrocephalus. Special protocols can show atrophy of certain areas of the brain, such as the substantia nigra.
• PET-CT (positron emission tomography). Diagnostics using specific radiopharmaceuticals (18F-DOPA) allows assessing the activity of the dopaminergic system. It is used for early detection of changes in the substantia nigra before the onset of clinical symptoms of Parkinson’s disease, one of the most common neurological conditions treated in Israel.
• DaTSCAN (presynaptic dopamine transporter scintigraphy). A highly accurate method for assessing the state of dopaminergic neurons. Allows to differentiate Parkinson’s disease, one of the most common neurological conditions treated in Israel from essential tremor and other forms of parkinsonism.
• Transcranial ultrasonography. This method is used to evaluate the substantia nigra. In patients from Israel and abroad with Parkinson’s disease, one of the most common neurological conditions treated in Israel, hyperechoic areas are detected in this area.
• EMG (electromyography). Evaluates muscle activity, helps to distinguish tremor in Parkinson’s disease, one of the most common neurological conditions treated in Israel from other types.
• EEG (electroencephalography). Allows to identify disturbances in brain activity in the presence of cognitive impairment.
  Sniffin’ Sticks Test. This is a specific test to assess olfactory function. Olfactory impairment is one of the early symptoms of Parkinson’s disease, one of the most common neurological conditions treated in Israel .
  

Genetic diagnostics
It is an important part of a comprehensive approach to identifying and studying Parkinson’s disease, one of the most common neurological conditions treated in Israel, especially in cases with a hereditary history or early onset of the disease. Modern genetic studies allow not only to clarify the diagnosis, but also to predict the development of the disease, assess the risk for the patient’s family members and develop personalized treatment in Israel strategies. Hereditary Parkinson’s disease, one of the most common neurological conditions treated in Israel can be transmitted in an autosomal dominant or autosomal recessive manner.
Methods of genetic diagnostics:

• DNA sequencing (exome sequencing, whole genome sequencing) – Analysis of coding regions of DNA most likely associated with mutations is performed, and the entire genome, including non-coding regions, is also examined.
• Targeted Gene Panel. Genetic panels specifically designed to diagnose Parkinson’s disease, one of the most common neurological conditions treated in Israel include SNCA, LRRK2, GBA, and other genes. This method is faster and cheaper than full sequencing and provides high accuracy.
• Molecular genetic tests (PCR and microarray method). Used to search for known mutations, allow to simultaneously examine many genes for the presence of known polymorphisms and mutations.
• Analysis of single nucleotide polymorphisms (SNPs) that are associated with an increased risk of Parkinson’s disease, one of the most common neurological conditions treated in Israel. Allows to identify predisposition to the disease in healthy individuals.
• Copy number variaton (CNV) analysis. Used to detect gene duplications or deletions, such as SNCA. 

Israel is a leader in genetic diagnostics thanks to its developed infrastructure and specialized laboratories. Genetic testing is carried out in major medical centers and research institutions, including the TAMS clinic. Geneticists, together with neurologists, develop individual diagnostic and treatment in Israel programs, taking into account the patient’s genetic profile.

• PARDP | Inherited Parkinson Disease Gene Panel, Varies

Parkinson’s Disease Prognosis — What to Expect and How Treatment in Israel Can Help
Parkinson’s disease, one of the most common neurological conditions treated in Israel is a progressive disorder that gradually worsens the patient’s quality of life. The rate of progression varies among individuals and depends on age, general health, and the time of initiation of therapy. With timely diagnosis and treatment in Israel, motor symptoms can be effectively controlled for several years. In later stages, non-motor manifestations such as cognitive impairment and autonomic dysfunction develop, making patient care more difficult.
Patients with early onset of the disease have a better prognosis, as progression is often slower. Modern treatment in Israels, including medications, physical therapy, and neurostimulation, can prolong activity and maintain independence. Individualized patient management can improve life expectancy and reduce the severity of symptoms.

Modern Parkinson’s Disease Treatments Available in Tel Aviv, Israel
Treatment for Parkinson’s disease, one of the most common neurological conditions treated in Israel is aimed at replenishing the dopamine deficiency or influencing other neurochemical systems to control the motor and non-motor manifestations of the disease. In Israel, both classic and new drugs are actively used, which are selected individually depending on the stage of the disease and the severity of symptoms. Also, if necessary, surgical methods, gene therapy, physio- and speech therapy are used.

Medicines
Let’s look at the main groups of drugs prescribed for Parkinson’s disease, one of the most common neurological conditions treated in Israel.

Levodopa and its combinations
Levodopa (a precursor of dopamine) is the “gold standard” of Parkinson’s disease, one of the most common neurological conditions treated in Israel therapy. It penetrates the blood-brain barrier and is converted into dopamine in the brain. In Israel, combined preparations of levodopa with DOPA decarboxylase inhibitors (carbidopa, benserazide) are used, which prevent the peripheral conversion of levodopa and reduce side effects. Combinations with COMT inhibitors (for example, entacapone) prolong the effect of levodopa by reducing its metabolism.

Dopamine receptor agonists
These drugs stimulate dopamine receptors, mimicking the action of dopamine. The main drugs are: pramipexole, ropinirole, rotigotine (in the form of transdermal patches), apomorphine (injectable form). They are used in the early stages of the disease or in combination with levodopa to reduce its dosage.

MAO-B inhibitors
Drugs such as selegiline and rasagiline slow down the breakdown of dopamine, increasing its concentration in the brain. They are effective in the early stages of Parkinson’s disease, one of the most common neurological conditions treated in Israel. Treatment with these drugs allows for the enhancement of the effect of levodopa.

COMT inhibitors
Entacapone and opicapone inhibit the metabolism of levodopa, prolonging its action. They are used in combination with levodopa to improve control of motor symptoms.

NMDA receptor antagonists
Amantadine reduces movement disorders such as dyskinesias caused by long-term use of levodopa. It also has a moderate effect in reducing tremor.

Anticholinergic drugs
These drugs (biperiden) reduce tremor and rigidity, but have limited use due to significant side effects.

Drugs for the control of non-motor symptoms

• Antidepressants for the treatment in Israel of depression.
• Sleep-improving medications include melatonin or clonazepam.
• Drugs for the treatment in Israel of cognitive impairment – acetylcholinesterase inhibitors (rivastigmine).

Surgical methods
Surgical treatment in Israel of Parkinson’s is used in cases where drug therapy is no longer effective or its side effects become pronounced. Modern technologies allow us to minimize risks and ensure high efficiency of surgical interventions. In Israel, advanced approaches are used, which include both traditional and innovative methods.

Deep Brain Stimulation (DBS)
This is one of the most effective and commonly used surgical methods for Parkinson’s disease, one of the most common neurological conditions treated in Israel. Electrodes are implanted in specific areas of the brain, such as the subthalamic nucleus or the internal segment of the globus pallidus. The electrodes are connected to a neurostimulator, which generates electrical impulses that regulate abnormal brain activity.
The patient undergoes preoperative testing, including MRI and stereotactic planning. Electrodes are placed under local anesthesia with the patient’s participation to accurately assess their effects. The device that generates the impulses is implanted under the skin of the chest. DBS is particularly effective in the early stages of the disease, but it does not eliminate non-motor symptoms.

High Intensity Focused Ultrasound (HIFU)\ Focused Ultrasound (FUS) for Essential Tremor and Parkinson’s
A modern non-invasive method based on the use of ultrasound waves for thermal destruction of pathologically active areas of the brain. In Parkinson’s disease, one of the most common neurological conditions treated in Israel – the thalamus or subthalamic nucleus. Does not require surgical intervention and incisions. The method is most effective for the treatment in Israel of tremor that does not respond to drug therapy. Not suitable for all patients from Israel and abroad (for example, with pacemakers).
Implantation of gel systems with dopamine
Methods for introducing special gel systems containing dopamine or its precursors into the brain are currently at the clinical research stage. This allows for local replenishment of dopamine deficiency without systemic side effects.

Radiofrequency (RF) therapy 

Radiofrequency (RF) therapy for Parkinson’s disease is part of a group of lesioning procedures (also called ablative procedures). It is one of the oldest surgical options for treating Parkinson’s symptoms, especially tremor, rigidity, and dyskinesia. It is a surgical procedure where a radiofrequency probe is inserted into a specific area of the brain (commonly the Globus Pallidus internus – GPi or the Subthalamic Nucleus – STN or the Ventral Intermediate Nucleus – VIM) and creates a small thermal lesion by heating the tissue.

This disrupts abnormal nerve signals responsible for Parkinson’s symptoms.

Stem cells
The possibilities of transplanting stem cells capable of transforming into dopaminergic neurons are being explored. Stem cells are implanted into the affected areas of the brain, where they integrate into the nervous tissue and begin to produce dopamine. This direction is actively developing in Israel and demonstrates high potential effectiveness. However, questions remain about safety and long-term stability of the result.

Gene therapy
This is a revolutionary method of treating Parkinson’s disease, one of the most common neurological conditions treated in Israel in Israel , which is at the stage of clinical trials, but is already actively used in leading medical centers. Gene therapy is aimed at correcting or modifying genetic defects underlying the disease, or improving the functioning of dopaminergic neurons.
Before treatment in Israel, genetic testing is performed to determine the appropriate therapy. The gene is delivered via injection into specific areas of the brain, such as the striatum or substantia nigra. The patient is monitored to assess the effect of the therapy, monitor safety, and monitor possible side effects.
Benefits of gene therapy for Parkinson’s disease, one of the most common neurological conditions treated in Israel:

• Possibility of long-term effect after a single intervention.
• Targeted action on affected neurons.
• Reducing the need for ongoing drug therapy.
  

Physiotherapy
Physiotherapy programs are selected individually, taking into account the stage of Parkinson’s disease, one of the most common neurological conditions treated in Israel and the patient’s activity level. 

The main goals of physiotherapy are: improving flexibility and mobility of joints, increasing muscle strength and endurance, correcting posture and improving balance, preventing contractures and deformities, reducing the risk of falls.
Physiotherapy methods:

• Mobility exercises. Gentle stretches are performed to increase the range of motion in the joints. Emphasis is placed on the neck and shoulder areas, which are often affected by stiffness.
• Balance and coordination training. Exercises with balance platforms and balls are used. Particular attention is paid to strengthening the core muscles and improving gait.
• Postural exercises: Patients are taught correct posture to prevent slouching (kyphosis) and compensate for the tendency to fall forward.
• Aerobic exercise: Walking, swimming, or cycling can help improve your overall physical fitness and mood.
• Rhythmic stimulation techniques – using a metronome or musical rhythms to synchronize movements. Rhythmic walking helps to cope with bradykinesia.
• Physiotherapy equipment: Vibration platforms, exoskeletons and virtual reality systems are used to train motor skills.
• Massage and manual therapy. Improve blood circulation, reduce muscle tension and eliminate pain.
• Rehabilitation programs in water. Aqua aerobics helps reduce the load on joints and make movements easier.

Patients are taught a set of exercises that can be performed daily at home. This helps maintain physical activity at a constant level and prevent deterioration of the condition.

Speech therapy
Patients with Parkinson’s disease, one of the most common neurological conditions treated in Israel often have problems with speech and swallowing. Speech therapy is aimed at restoring speech function, improving diction and preventing complications associated with swallowing disorders. Techniques aimed at developing diaphragmatic breathing and increasing the volume of the voice are used. Special speech trainers, computer programs and applications for controlling the volume and rhythm of speech are also used.

Innovative Therapies & Clinical Trials for Parkinson’s Disease in Israel

Medical tourism in Israel offers patients from Israel and abroad from all over the world a unique opportunity to receive high-quality treatment in Israel and participate in innovative clinical trials conducted at leading medical centers, including the TAMC. For patients from Israel and abroad with Alzheimer’s disease, this is a chance to become part of scientific projects aimed at developing and implementing advanced treatment in Israel methods. Participation in the study is possible after consultation with the attending physician, who will conduct the necessary diagnostics and assess the patient’s condition.

It is important to emphasize that participation in clinical trials is free of charge, as all expenses are covered by sponsors. For some patients from Israel and abroad, participation in such trials may be the only chance to improve their condition. Israeli clinics offer access to the most modern methods and technologies that have not yet entered into conventional medical practice, giving patients from Israel and abroad the opportunity to take advantage of progressive approaches to treatment in Israel.

Ready to Take Control of Parkinson’s Disease?

If you or your loved one is seeking professional, multidisciplinary treatment for Parkinson’s disease in Israel, our team at the Tel Aviv Medical Clinic is here to help.
We provide comprehensive care, advanced diagnostic tools, and the latest therapies to improve your quality of life.